Search research articles
Contact Us
Filters
Showing results (251-260 of 271) with videos related to
Page
of 28
Sort By:
Mbio
|
May 23, 2025
Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication
Jessica J Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
Mbio
|
April 14, 2026
Correction for Pfannenstiel et al., "Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication"
Jessica J Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
European Journal of Preventive Cardiology
|
October 8, 2022
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)
Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, et al.
European Journal of Preventive Cardiology
|
February 9, 2023
Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease
Tinka J van Trier, Marjolein Snaterse, Steven H J Hageman, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 10, 2025
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention
Steven H J Hageman, Stephen Kaptoge, Mari N Gynnild, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model
Marga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2007
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase
Scott D Larsen, Zhijun Zhang, Brian A DiPaolo, et al.
International Journal of Cardiology
|
September 7, 2024
Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohort
Joshua A N van Apeldoorn, Steven H J Hageman, Ralf E Harskamp, et al.
Frontiers in Nutrition
|
December 5, 2022
Effects of a nutritional intervention on impaired behavior and cognitive function in an emphysematous murine model of COPD with endotoxin-induced lung inflammation
Charlotte E Pelgrim, Ingrid van Ark, Ronja E van Berkum, et al.
European Journal of Preventive Cardiology
|
June 2, 2023
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2
Steven H J Hageman, Carmen Petitjaen, Lisa Pennells, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 271) with videos related to
Sort By:
Page
of 28
Mbio
|
May 23, 2025
Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication
Jessica J Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
Mbio
|
April 14, 2026
Correction for Pfannenstiel et al., "Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication"
Jessica J Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
European Journal of Preventive Cardiology
|
October 8, 2022
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)
Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, et al.
European Journal of Preventive Cardiology
|
February 9, 2023
Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease
Tinka J van Trier, Marjolein Snaterse, Steven H J Hageman, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 10, 2025
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention
Steven H J Hageman, Stephen Kaptoge, Mari N Gynnild, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model
Marga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2007
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase
Scott D Larsen, Zhijun Zhang, Brian A DiPaolo, et al.
International Journal of Cardiology
|
September 7, 2024
Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohort
Joshua A N van Apeldoorn, Steven H J Hageman, Ralf E Harskamp, et al.
Frontiers in Nutrition
|
December 5, 2022
Effects of a nutritional intervention on impaired behavior and cognitive function in an emphysematous murine model of COPD with endotoxin-induced lung inflammation
Charlotte E Pelgrim, Ingrid van Ark, Ronja E van Berkum, et al.
European Journal of Preventive Cardiology
|
June 2, 2023
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2
Steven H J Hageman, Carmen Petitjaen, Lisa Pennells, et al.
Page
of 28